{"url_path":"/sec/bngo/8-k/2026-06-05/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000036-index.html","accession_number":"0001411690-26-000036","cik":"0001411690","ticker":"BNGO","issuer_name":"Bionano Genomics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000036-index.html","primary_entity_key":"0001411690","primary_entity_name":"Bionano Genomics, Inc."},"word_count":101,"has_tables":true,"body_markdown":"Item 5.02.\n\nDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nDeparture of Chief Medical Officer\n\n \n\nOn June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the “Company”) effective July 5, 2026.\n\n \n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nBionano Genomics, Inc.\n\n \n\n \n\n \n\n \n\nDate: June 5, 2026\n\nBy:\n\n/s/ Albert A. Luderer, Ph.D.\n\n \n\n \n\nAlbert A. Luderer, Ph.D.\n\n \n\n \n\nInterim Chief Executive Officer"}